<h3>漲幅榜</h3>
<ul>
<li><strong>Polaryx Therapeutics</strong> (NASDAQ: PLYX) 的股票在週二的常規交易中上漲了 80.9%，至 $4.36。該公司的市值為 1.14 億美元。</li>
<li><strong>Baird Medical Investment</strong> (NASDAQ: BDMD) 的股票上漲了 45.25%，至 $1.12。該公司的市值為 2820 萬美元。</li>
<li><strong>Compass Pathways</strong> (NASDAQ: CMPS) 的股票上漲了 42.42%，至 $8.28。其流通股的市場價值為 5.435 億美元。</li>
<li><strong>Masimo</strong> (NASDAQ: MASI) 的股票上漲了 34.4%，至 $174.93。其流通股的市場價值為 70 億美元。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 的股票上漲了 28.68%，至 $0.56。該公司的市值為 150 萬美元。</li>
<li><strong>Biodexa Pharmaceuticals</strong> (NASDAQ: BDRX) 的股票上漲了 21.75%，至 $1.31。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>Liminatus Pharma</strong> (NASDAQ: LIMN) 的股票在週二的常規交易中下跌了 33.9%，至 $0.25。該公司的市值為 1010 萬美元。</li>
<li><strong>Ocular Therapeutix</strong> (NASDAQ: OCUL) 的股票下跌了 24.84%，至 $6.67。其流通股的市場價值為 19 億美元。</li>
<li><strong>Mainz Biomed</strong> (NASDAQ: MYNZ) 的股票下跌了 22.67%，至 $0.62。該公司的市值為 680 萬美元。</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) 的股票下跌了 18.25%，至 $0.28。其流通股的市場價值為 200 萬美元。</li>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) 的股票下跌了 15.06%，至 $0.17。該公司的市值為 1110 萬美元。</li>
<li><strong>Solid Biosciences</strong> (NASDAQ: SLDB) 的股票下跌了 14.22%，至 $5.31。其流通股的市場價值為 4.82 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

LIMN

IBBQ

2 倍做多納斯達克生物技術 ETF - ProShares

<p>在週二的盤中交易中，Polaryx Therapeutics (PLYX) 錄得顯著上漲，漲幅達到 80.9%，價格為 4.36 美元，市值為 1.14 億美元。其他 notable 的漲幅股票包括 Baird Medical Investment (BDMD) 上漲 45.25%，Compass Pathways (CMPS) 上漲 42.42%，以及 Masimo (MASI) 上漲 34.4%。相反，Liminatus Pharma (LIMN) 錄得最大跌幅，下跌 33.9%，至 0.25 美元。其他下跌的股票包括 Ocular Therapeutix (OCUL) 下跌 24.84% 和 Mainz Biomed (MYNZ) 下跌 22.67%</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅榜</h3>
</div><ul>
<li><strong>Polaryx Therapeutics</strong> (NASDAQ: PLYX) shares increased by 80.9% to $4.36 during Tuesday's regular session. The company's market cap stands at $114.0 million.</li>
<li><strong>Baird Medical Investment</strong> (NASDAQ: BDMD) stock increased by 45.25% to $1.12. The company's market cap stands at $28.2 million.</li>
<li><strong>Compass Pathways</strong> (NASDAQ: CMPS) stock increased by 42.42% to $8.28. The market value of their outstanding shares is at $543.5 million.</li>
<li><strong>Masimo</strong> (NASDAQ: MASI) shares moved upwards by 34.4% to $174.93. The market value of their outstanding shares is at $7.0 billion.</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) shares increased by 28.68% to $0.56. The company's market cap stands at $1.5 million.</li>
<li><strong>Biodexa Pharmaceuticals</strong> (NASDAQ: BDRX) stock increased by 21.75% to $1.31.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Polaryx Therapeutics</strong> (NASDAQ: PLYX) 的股票在週二的常規交易中上漲了 80.9%，至 $4.36。該公司的市值為 1.14 億美元。</li>
<li><strong>Baird Medical Investment</strong> (NASDAQ: BDMD) 的股票上漲了 45.25%，至 $1.12。該公司的市值為 2820 萬美元。</li>
<li><strong>Compass Pathways</strong> (NASDAQ: CMPS) 的股票上漲了 42.42%，至 $8.28。其流通股的市場價值為 5.435 億美元。</li>
<li><strong>Masimo</strong> (NASDAQ: MASI) 的股票上漲了 34.4%，至 $174.93。其流通股的市場價值為 70 億美元。</li>
<li><strong>Ensysce Biosciences</strong> (NASDAQ: ENSC) 的股票上漲了 28.68%，至 $0.56。該公司的市值為 150 萬美元。</li>
<li><strong>Biodexa Pharmaceuticals</strong> (NASDAQ: BDRX) 的股票上漲了 21.75%，至 $1.31。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>Liminatus Pharma</strong> (NASDAQ: LIMN) shares fell 33.9% to $0.25 during Tuesday's regular session. The company's market cap stands at $10.1 million.</li>
<li><strong>Ocular Therapeutix</strong> (NASDAQ: OCUL) shares decreased by 24.84% to $6.67. The market value of their outstanding shares is at $1.9 billion.</li>
<li><strong>Mainz Biomed</strong> (NASDAQ: MYNZ) shares fell 22.67% to $0.62. The company's market cap stands at $6.8 million.</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) stock fell 18.25% to $0.28. The market value of their outstanding shares is at $2.0 million.</li>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) shares declined by 15.06% to $0.17. The company's market cap stands at $11.1 million.</li>
<li><strong>Solid Biosciences</strong> (NASDAQ: SLDB) shares fell 14.22% to $5.31. The market value of their outstanding shares is at $482.0 million.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Liminatus Pharma</strong> (NASDAQ: LIMN) 的股票在週二的常規交易中下跌了 33.9%，至 $0.25。該公司的市值為 1010 萬美元。</li>
<li><strong>Ocular Therapeutix</strong> (NASDAQ: OCUL) 的股票下跌了 24.84%，至 $6.67。其流通股的市場價值為 19 億美元。</li>
<li><strong>Mainz Biomed</strong> (NASDAQ: MYNZ) 的股票下跌了 22.67%，至 $0.62。該公司的市值為 680 萬美元。</li>
<li><strong>Strata Skin Sciences</strong> (NASDAQ: SSKN) 的股票下跌了 18.25%，至 $0.28。其流通股的市場價值為 200 萬美元。</li>
<li><strong>Quince Therapeutics</strong> (NASDAQ: QNCX) 的股票下跌了 15.06%，至 $0.17。該公司的市值為 1110 萬美元。</li>
<li><strong>Solid Biosciences</strong> (NASDAQ: SLDB) 的股票下跌了 14.22%，至 $5.31。其流通股的市場價值為 4.82 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週二盤中交易中出現波動